Curaleaf Executive Chairman Boris Jordan Named to Bloomberg Businessweek's 2019 Bloomberg 50 List

The annual list includes innovators, entrepreneurs, and leaders who have changed the global business landscape in measurable ways over the past year

WAKEFIELD, Mass., Dec. 4, 2019 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”), a leading vertically integrated cannabis operator in the United States, is proud to announce that Curaleaf Executive Chairman Boris Jordan has been named to Bloomberg Businessweek’s 2019 Bloomberg 50, its annual list of innovators, entrepreneurs, and leaders who have changed the global business landscape in measurable ways over the past year.

Under Jordan’s leadership, Curaleaf is positioned to become the world’s largest cannabis company. In 2019 alone, Curaleaf announced the acquisitions of Select, the leading cannabis wholesale brand in the United States, and Grassroots, which will expand Curaleaf’s presence from 12 to 19 states. The acquisitions will bring together the fastest growing cannabis brands and create an unmatched national platform and economies of scale.

  Subscribe to news from
Kalytera Therapeutics

Be the first to know when breaking news are released.

An unranked list, the Bloomberg 50 represents the most influential thought leaders in business, entertainment, finance, politics, science, and technology whose 2019 accomplishments were particularly noteworthy. The list will be published in a special issue of Bloomberg Businessweek, on newsstands on Friday, Dec. 6, 2019.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 51 dispensaries, 14 cultivation sites and 13 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, ” expects” or, “proposed”, “is expected”, “intends”, “anticipates”, ” or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward‐looking statements and information concerning Curaleaf’s acquisition strategy and expansion. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Other factors that could adversely affect our business and prospects are set forth in our public filings with the Canadian Securities Exchange. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release.

Investor Contact:
Curaleaf Holdings, Inc.
Daniel Foley, VP, Corporate Finance & Investor Relations 

Media Contact:
Megan Bishop, SVP


View original content:

SOURCE Curaleaf Holdings, Inc.